Limited time: $75 off your first protocol with code PEPTIDE75

Hormonal Protocol13 min read

Kisspeptin Protocol Guide: The Complete Physician-Supervised Approach to Hormonal & Fertility Support

Kisspeptin is the master regulator of the reproductive hormone axis. Discovered in 2003 as the signal that initiates puberty and maintains reproductive function, Kisspeptin is now being explored as a therapeutic tool for hypogonadism, infertility, and sexual dysfunction. This guide covers physician-supervised protocols for hormonal optimization.

Protocol Quick Reference

Peptide:Kisspeptin-10 (Metastin 45-54)
Dosage Range:1-10 mcg/kg subcutaneous
Duration:As needed or cyclical (physician-guided)
Best For:Reproductive hormones, libido, fertility
Administration:Subcutaneous injection
Stacks With:PT-141, Gonadorelin

Who Is This Protocol For?

Kisspeptin is suited for individuals with hypothalamic-pituitary-gonadal (HPG) axis dysfunction or those seeking natural stimulation of reproductive hormones. It works upstream of GnRH, making it the most physiological approach to hormone restoration. Common candidates include:

  • Men with hypogonadotropic hypogonadism where the brain is not adequately signaling the testes to produce testosterone, including post-steroid PCT support
  • Women undergoing IVF or fertility treatment where Kisspeptin may provide a safer alternative to hCG for triggering ovulation
  • Individuals with low libido related to hypothalamic dysfunction, chronic stress, or hormonal imbalance
  • Those with functional hypothalamic amenorrhea (women whose periods have stopped due to stress, over-exercise, or under-eating)
  • Men and women seeking natural hormone optimization without directly administering testosterone or estrogen

Kisspeptin is not recommended for individuals with hormone-sensitive cancers (breast, prostate, ovarian), those with precocious puberty, pregnant women, or individuals with pituitary tumors that secrete gonadotropins. Comprehensive hormonal evaluation is mandatory before prescribing.

How Kisspeptin Works: Mechanism of Action

Kisspeptin is a neuropeptide encoded by the KISS1 gene. Kisspeptin neurons in the hypothalamus act as the master switch for the reproductive axis — they directly stimulate GnRH (gonadotropin-releasing hormone) neurons, which in turn trigger LH and FSH release from the pituitary.

Primary Mechanisms

  • GnRH neuron activation: Kisspeptin binds to the GPR54 receptor (KISS1R) on GnRH neurons in the hypothalamus, directly stimulating GnRH release. A single bolus of Kisspeptin produces a robust, dose-dependent surge in LH and FSH within 30-60 minutes.
  • LH and FSH stimulation: Through GnRH, Kisspeptin increases luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — the gonadotropins that drive testosterone production in men and estrogen/progesterone production and ovulation in women.
  • Testosterone restoration in men: By stimulating the natural LH pulse, Kisspeptin promotes endogenous testosterone production from the Leydig cells of the testes. Clinical studies show significant testosterone increases within hours of administration.
  • Ovulation triggering in women: Kisspeptin can trigger the LH surge necessary for ovulation, providing a potentially safer alternative to hCG in IVF protocols with lower risk of ovarian hyperstimulation syndrome (OHSS).
  • Libido and sexual arousal: Beyond hormonal effects, Kisspeptin has direct effects on brain regions involved in sexual arousal. fMRI studies show it activates limbic structures associated with sexual processing, attraction, and bonding behavior.

Clinical Note: Kisspeptin research is advancing rapidly. Professor Waljit Dhillo's group at Imperial College London has conducted multiple human studies demonstrating Kisspeptin's ability to restore LH pulsatility, trigger ovulation, and enhance sexual brain processing. Phase 2 clinical trials for IVF applications are ongoing.

Detailed Protocol

Kisspeptin protocols vary significantly based on the clinical indication. Fertility protocols differ substantially from hormone optimization or libido protocols. Your Hatter Labs physician will design a protocol specific to your goals.

ParameterHormone OptimizationFertility Support
Dosage1-5 mcg/kg per dose5-10 mcg/kg per dose
Frequency2-3x per week or as neededTimed to cycle (physician-directed)
AdministrationSubcutaneous injectionSubcutaneous or IV (clinical setting)
Injection SiteAbdominal fat padAbdominal fat pad
Duration4-8 weeks cyclicalPer IVF/fertility cycle
Time of DayMorning or evening (consistent)Cycle-dependent timing
MonitoringLH, FSH, testosterone/estradiol, SHBGUltrasound + hormonal panel per cycle

Personalization Note: Kisspeptin dosing is weight-based (mcg/kg) and highly individualized. Hatter Labs physicians perform comprehensive hormonal panels (total and free testosterone, estradiol, LH, FSH, SHBG, prolactin, thyroid panel) before prescribing. For fertility applications, coordination with a reproductive endocrinologist is standard.

What to Expect: Results Timeline

Hours 1-6: Acute Hormonal Response

  • - Rapid increase in LH within 30-60 minutes of injection
  • - Corresponding testosterone rise in men (measurable within 4-6 hours)
  • - Some individuals report an acute sense of warmth, energy, or arousal
  • - Fertility protocols: LH surge capable of triggering ovulation

Week 1-4: Hormonal Optimization Phase

  • - Improved libido and sexual function with repeated dosing
  • - Testosterone levels trending upward on serial bloodwork (men)
  • - Restoration of menstrual cycle regularity (women with hypothalamic amenorrhea)
  • - Enhanced mood, motivation, and energy levels
  • - Improved sense of wellbeing and vitality

Week 5-8+: Sustained Benefits

  • - Stabilized hormone levels within optimal range
  • - Sustained improvements in libido and sexual satisfaction
  • - Body composition improvements driven by optimized testosterone
  • - Fertility outcomes for those in treatment cycles
  • - Your physician evaluates long-term strategy and cycling needs

Kisspeptin produces both acute hormonal effects (within hours) and cumulative benefits with repeated dosing. The acute nature of its action makes it uniquely suited for targeted applications like ovulation triggering and on-demand hormonal support.

Potential Side Effects

Kisspeptin is a naturally occurring neuropeptide, and exogenous administration has shown a favorable safety profile in clinical studies. Side effects are generally mild and transient.

Common (mild, usually transient)

  • Injection site redness or minor discomfort
  • Facial flushing or warmth lasting 15-30 minutes after injection
  • Mild headache
  • Temporary increase in body temperature
  • Heightened emotional sensitivity or arousal

Uncommon (report to your physician)

  • Persistent headaches or nausea
  • Ovarian hyperstimulation symptoms in women (abdominal bloating, pain)
  • Mood swings beyond expected hormonal fluctuation
  • Allergic reaction (rash, swelling, difficulty breathing) — seek immediate medical attention

Safety Note: Continuous high-dose Kisspeptin administration can desensitize GnRH neurons, paradoxically suppressing rather than stimulating reproductive hormones (similar to GnRH agonist medications used for prostate cancer). This is why pulsatile or intermittent dosing is essential. Your Hatter Labs physician designs protocols to avoid tachyphylaxis.

Stacking Options

Kisspeptin can be combined with other peptides that support sexual function and hormonal health through complementary mechanisms.

Kisspeptin + PT-141

A comprehensive sexual function stack. Kisspeptin addresses the hormonal foundation (LH, testosterone, estrogen) while PT-141 (bremelanotide) directly activates central nervous system pathways for sexual arousal. Together they address both the hormonal and neurological components of sexual dysfunction.

Typical protocol: Kisspeptin 1-5 mcg/kg 2-3x/week + PT-141 1.75 mg as needed (max 1x/24h) | 4-8 weeks

Kisspeptin + Gonadorelin

Dual-pathway GnRH axis stimulation. Kisspeptin stimulates endogenous GnRH production while Gonadorelin provides direct GnRH receptor stimulation at the pituitary. This combination is particularly useful for men recovering from exogenous testosterone or steroid use who need comprehensive HPG axis restoration.

Typical protocol: Kisspeptin 1-5 mcg/kg 2-3x/week + Gonadorelin 50-100 mcg 2x/week | 4-8 weeks

Kisspeptin + PT-141 + Gonadorelin (Hormonal Restoration Stack)

The complete approach to sexual and hormonal health. Upstream hypothalamic stimulation (Kisspeptin), direct pituitary support (Gonadorelin), and central arousal activation (PT-141). This stack addresses hormonal, neurological, and psychological aspects of sexual function simultaneously.

Typical protocol: Physician-customized based on hormonal panel and specific dysfunction | 6-8 weeks

Why Run Your Kisspeptin Protocol with Hatter Labs

Kisspeptin therapy requires careful hormonal evaluation, weight-based dosing, and regular lab monitoring. Whether you are addressing fertility, low testosterone, or sexual dysfunction, Hatter Labs provides the clinical expertise and discreet care to optimize your protocol.

Physician-Supervised Protocols

Licensed physicians design and monitor your protocol from start to finish

Personalized Dosing Based on Labs

Complete hormonal panels, LH/FSH, testosterone, and SHBG guide your protocol

Direct Doctor Chat & Remote Consultations

Message your physician anytime with questions or concerns, schedule video calls

Before & After Lab Testing

Track hormonal panels, fertility markers, and metabolic health objectively

Pharmaceutical-Grade Compounds

Premium peptides sourced from licensed US compounding pharmacies with full purity testing

Start Your Kisspeptin Protocol

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Kisspeptin is a research peptide that requires a physician prescription. Individual results vary. Always consult with a qualified healthcare provider before starting any peptide therapy protocol. Hatter Labs protocols are supervised by licensed physicians who evaluate your health history, contraindications, and treatment goals before prescribing.